Why CAR T cell therapy fails in renal cell carcinoma - Top-Institutions - MDSpire

Why CAR T cell therapy fails in renal cell carcinoma

  • By

  • Hua-jun Zhang

  • Lv-zhou Han

  • Xiang Zhang

  • Yang-lu Ge

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    National Cancer Institute’s Center for Cancer Research
    National Cancer Institute’s Center for Cancer Research

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #4

    Fred Hutchinson Cancer Research Center
    Fred Hutchinson Cancer Research Center

    Seattle, Washington

    Key Differentiators

    • Oncology

  • #5

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology

Original Source(s)

Why CAR T cell therapy fails in renal cell carcinoma

  • by Hua-jun Zhang, Lv-zhou Han, Xiang Zhang, Yang-lu Ge

  • June 11, 2026

Related Content

Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

Multimodal treatment and long-term survival in a rare case of melanoma with pancreatic and splenic metastases: a case report and literature review